Press release
Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size is Estimated to Reach ~USD 2 billion by 2027 | Transparency Market Research
Non-alcoholic Steatohepatitis (NASH) Biomarkers market is estimated to attain a valuation of ~US$ 2 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of ~21% during the forecast period, 2019-2027
Get a Sample Copy of the Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Research Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18650&utm_source=openpr_amitugare&utm_medium=openpr
The significant players operating in the global Non-alcoholic Steatohepatitis (NASH) Biomarkers market are
Biopredictive, Quest Diagnostics, Exalenz Bioscience Ltd, GENFIT, Siemens Healthineers
Key Drivers: Several key drivers contribute to the growth and advancement of the NASH Biomarkers Market:
Rising Global Burden of NASH and Metabolic Syndrome: The escalating prevalence of obesity, diabetes, and metabolic syndrome worldwide contributes to the increasing incidence and prevalence of NASH, driving demand for reliable biomarkers for early detection, risk assessment, and disease monitoring in high-risk populations.
Challenges in NASH Diagnosis and Disease Management: NASH is often asymptomatic and difficult to diagnose based on clinical signs and symptoms alone, necessitating the development of accurate, non-invasive biomarkers for identifying individuals at risk of NASH progression, monitoring disease activity, and guiding treatment decisions in clinical practice.
Advancements in Biomarker Discovery and Validation: Ongoing advancements in biomarker discovery technologies, omics technologies, and bioinformatics enable the identification and validation of novel biomarkers and molecular signatures associated with NASH pathogenesis, fibrosis progression, and treatment response, paving the way for personalized medicine approaches in NASH management.
Regulatory Initiatives and Drug Development Landscape: Regulatory agencies and pharmaceutical companies are investing in biomarker-driven drug development strategies for NASH therapeutics, with an emphasis on identifying surrogate endpoints, predictive biomarkers, and pharmacodynamic markers to facilitate clinical trial design, patient selection, and treatment response assessment in NASH clinical trials.
Buy this Premium Research Report: - https://www.transparencymarketresearch.com/checkout.php?rep_id=18650<ype=S
Recent Developments with Regional Analysis: In recent years, the NASH Biomarkers Market has witnessed notable developments and trends, accompanied by regional variations and market dynamics:
Emergence of Non-invasive Biomarker Panels: Non-invasive biomarker panels combining multiple serum biomarkers, imaging techniques, and clinical parameters offer promising tools for diagnosing NASH, staging liver fibrosis, and assessing disease severity, providing alternatives to liver biopsy and enabling longitudinal monitoring of disease progression and treatment response.
Regional Disparities in Biomarker Adoption and Healthcare Infrastructure: Variations in healthcare infrastructure, access to diagnostic testing, and regulatory approval processes contribute to regional disparities in biomarker adoption and clinical practice guidelines for NASH diagnosis and management, highlighting the need for standardized approaches and collaborative research initiatives to address unmet medical needs in diverse healthcare settings.
Focus on Precision Medicine and Personalized Treatment Strategies: Precision medicine approaches in NASH management aim to stratify patients based on their unique disease phenotypes, genetic profiles, and biomarker signatures, enabling tailored treatment strategies and targeted therapies to address specific pathophysiological mechanisms underlying NASH progression and fibrosis development.
Collaborative Research Consortia and Consortia Initiatives: Collaborative research consortia, such as the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) and the European NAFLD Registry (ERN), facilitate multi-center studies, data sharing, and collaborative biomarker research initiatives to accelerate biomarker validation, standardization, and implementation in clinical practice and drug development efforts.
Market Segmentation -
Biomarker Type
Serum Biomarkers
Cytokeratin-18 (CK 18)-Biomarker
Inflammatory Markers
Others
Biomarker Panels
Fibrosis Biomarkers
Imaging Biomarkers
Others
End User
Hospitals
Diagnostic Centers
Others
This Report lets you identify the opportunities in Non-alcoholic Steatohepatitis (NASH) Biomarkers Market by means of a region:
North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)
Reasons to Buy The Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Report: -
1.Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.
2.Reports provide opportunities and threats faced by suppliers in the Non-alcoholic Steatohepatitis (NASH) Biomarkers industry around the world.
The report shows regions and sectors with the fastest growth potential.
3.A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.
4.The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.
5.This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.
More Trending Reports by Transparency Market Research -
Acute Migraine Treatment Market- https://www.globenewswire.com/en/news-release/2023/08/18/2727843/32656/en/Acute-Migraine-Treatment-Market-Predicted-to-Reach-USD-7-billion-by-2031-Recording-Over-a-15-CAGR-Says-Transparency-Market-Research.html
Photodynamic Therapy Market- https://www.globenewswire.com/en/news-release/2023/07/17/2705951/32656/en/Photodynamic-Therapy-Market-to-Grow-at-a-CAGR-of-13-5-from-2022-to-2031-reaching-US-15-5-Billion-As-per-TMR-Study.html
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size is Estimated to Reach ~USD 2 billion by 2027 | Transparency Market Research here
News-ID: 3413075 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for NASH
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
